TherapeuticsMD, Inc. (TXMD) stock
TXMDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 12/3026% below fair value
$1.81−0.10 (-5.24%)
Close on Nov 18, 2026Market cap $20.95MP/E –Yield –
TherapeuticsMD shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
TherapeuticsMD's shares outstanding was 12M at Jun 30, 2026. For fiscal 2025 it was 12M, up 0.3% from the year before. Over ten years it grew 12.8% a year on average. The highest annual figure on record is 12M in fiscal 2025.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 12M | +0.3% |
| FY2024 | Dec 31, 2024 | 12M | +110349.2% |
| FY2023 | Dec 31, 2023 | 0M | -99.9% |
| FY2022 | Dec 31, 2022 | 9M | +17.7% |
| FY2021 | Dec 31, 2021 | 8M | +44.4% |
| FY2020 | Dec 31, 2020 | 6M | +11.9% |
| FY2019 | Dec 31, 2019 | 5M | +9.5% |
| FY2018 | Dec 31, 2018 | 5M | +9.5% |
| FY2017 | Dec 31, 2017 | 4M | +4.8% |
| FY2016 | Dec 31, 2016 | 4M | +13.2% |
| FY2015 | Dec 31, 2015 | 3M | +15.7% |
| FY2014 | Dec 31, 2014 | 3M | +17.4% |
| FY2013 | Dec 31, 2013 | 3M | +39.2% |
| FY2012 | Dec 31, 2012 | 2M | +46.6% |
| FY2011 | Dec 31, 2011 | 1M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | 12M | +0.6% |
| Q1 FY2026 | Mar 31, 2026 | 0M | +0.8% |
| Q4 FY2025 | Dec 31, 2025 | 12M | +0.4% |
| Q3 FY2025 | Sep 30, 2025 | 12M | +0.4% |
| Q2 FY2025 | Jun 30, 2025 | 12M | +0.4% |
| Q1 FY2025 | Mar 31, 2025 | 0M | -99.9% |
| Q4 FY2024 | Dec 31, 2024 | 12M | +7.8% |
| Q3 FY2024 | Sep 30, 2024 | 12M | +12.8% |
| Q2 FY2024 | Jun 30, 2024 | 12M | +18.2% |
| Q1 FY2024 | Mar 31, 2024 | 12M | +6.5% |
| Q3 FY2023 | Sep 30, 2023 | 11M | +15.5% |
| Q2 FY2023 | Jun 30, 2023 | 10M | +16.8% |
| Q1 FY2023 | Mar 31, 2023 | 10M | +13.2% |
| Q4 FY2022 | Dec 31, 2022 | 11M | +26.6% |
| Q3 FY2022 | Sep 30, 2022 | 9M | +9.7% |
| Q2 FY2022 | Jun 30, 2022 | 9M | +11.0% |
| Q1 FY2022 | Mar 31, 2022 | 9M | +24.0% |
| Q4 FY2021 | Dec 31, 2021 | 9M | +49.2% |
| Q3 FY2021 | Sep 30, 2021 | 8M | +54.9% |
| Q2 FY2021 | Jun 30, 2021 | 8M | +44.9% |
| Q1 FY2021 | Mar 31, 2021 | 7M | +27.9% |
| Q4 FY2020 | Dec 31, 2020 | 6M | +9.5% |
| Q3 FY2020 | Sep 30, 2020 | 5M | +13.0% |
| Q2 FY2020 | Jun 30, 2020 | 5M | +12.7% |
| Q1 FY2020 | Mar 31, 2020 | 5M | +12.6% |
| Q4 FY2019 | Dec 31, 2019 | 5M | +9.7% |
| Q3 FY2019 | Sep 30, 2019 | 5M | +5.8% |
| Q2 FY2019 | Jun 30, 2019 | 5M | +11.3% |
| Q1 FY2019 | Mar 31, 2019 | 5M | +11.3% |
| Q4 FY2018 | Dec 31, 2018 | 5M | +12.5% |
| Q3 FY2018 | Sep 30, 2018 | 5M | +9.7% |
| Q2 FY2018 | Jun 30, 2018 | 4M | +6.5% |
| Q1 FY2018 | Mar 31, 2018 | 4M | +9.5% |
| Q4 FY2017 | Dec 31, 2017 | 4M | +7.9% |
| Q3 FY2017 | Sep 30, 2017 | 4M | +5.8% |
| Q2 FY2017 | Jun 30, 2017 | 4M | – |
| Q1 FY2017 | Mar 31, 2017 | 4M | – |
| Q4 FY2016 | Dec 31, 2016 | 4M | – |
| Q3 FY2016 | Sep 30, 2016 | 4M | – |
See a number that looks wrong?